Cargando…
New Perspectives on Polycythemia Vera: From Diagnosis to Therapy
Polycythemia vera (PV) is mainly characterized by elevated blood cell counts, thrombotic as well as hemorrhagic predisposition, a variety of symptoms, and cumulative risks of fibrotic progression and/or leukemic evolution over time. Major changes to its diagnostic criteria were made in the 2016 revi...
Autores principales: | Iurlo, Alessandra, Cattaneo, Daniele, Bucelli, Cristina, Baldini, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461104/ https://www.ncbi.nlm.nih.gov/pubmed/32823537 http://dx.doi.org/10.3390/ijms21165805 |
Ejemplares similares
-
Erdheim–Chester Disease With Multiorgan Involvement, Following Polycythemia Vera: A Case Report
por: Iurlo, Alessandra, et al.
Publicado: (2016) -
Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge
por: Iurlo, Alessandra, et al.
Publicado: (2021) -
Management of polycythemia vera: A survey of treatment patterns in Italy
por: Palumbo, Giuseppe Alberto, et al.
Publicado: (2022) -
Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera
por: Benevolo, Giulia, et al.
Publicado: (2023) -
Genetic Background of Polycythemia Vera
por: Regimbeau, Mathilde, et al.
Publicado: (2022)